https://www.selleckchem.com/pr....oducts/abr-238901.ht
In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial infarction (AMI) in Turkey. The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of 24/7 primary percutaneous coronary intervention (PCI). All consecutive patients (n=193 with AMI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefine
Мне нравится
Комментарий
Перепост
